The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
SSR180575 (7-Chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4 H-pyridazino[4,5-b]indole-1-acetamide), a Peripheral Benzodiazepine Receptor Ligand, Promotes Neuronal Survival and Repair
Abstract
In the present study, we have investigated the potential neuroprotective effects of a novel peripheral benzodiazepine binding site (PBR) ligand, 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (SSR180575), in models of central and peripheral neurodegeneration in vivo and its effect on steroid concentrations in plasma and nervous tissue. SSR180575 shows high affinity (IC(50), 2.5-3.5 nM) and selectivity for the rat and human PBR and potently inhibits the in vivo binding of [(3)H]alpidem to PBR in the rat brain and spleen after oral or i.p. administration (ID(50), 0.1-0.3 mg/kg). In an experimental model of motoneuron degeneration induced by facial nerve axotomy in the immature rat, SSR180575 given i.p. or orally for 8 days rescued facial motoneurons, increasing their survival by 40 to 72% at 6 and 10 mg/kg p.o. b.i.d. Moreover, in this model, SSR180575 (10 mg/kg p.o. b.i.d.) increased by 87% the number of motoneurons immunoreactive to peripherin, a type III intermediate filament, whose expression is up-regulated during nerve regeneration. SSR180575 also improved functional recovery in acrylamide-induced neuropathy in the rat when given therapeutically at 2.5 to 10 mg/kg/day p.o. Furthermore, SSR180575 (3 mg/kg i.p. b.i.d.) accelerated functional recovery of the blink reflex after local injury of the facial nerve in the rat. SSR180575 increased pregnenolone accumulation in the brain and sciatic nerve (+100% at 3 mg/kg i.p.), suggesting…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TSPO is involved in the mitochondrial intermembrane transport of cholesterol”
From Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease (2023) · cites this paper as [53]
In the citing paper
“cholesterol which is the necessary precursor for the synthesis of neurosteroids [53–56]”
From Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease (2023) · cites this paper as [53]
Citations
Cites
DeLÉAN, A., Munson, P. J., & Rodbard, D. (1978) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1978.235.2.e97 · Cited by 2,384
THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,975
The cellular and molecular basis of peripheral nerve regeneration
Fu, S. Y., & Gordon, T. (1997) · Molecular Neurobiology · doi:10.1007/bf02740621 · Cited by 1,203
McEnery, M. W., Snowman, A. M., Trifiletti, R. R., & Snyder, S. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3170 · Cited by 708
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane.
Anholt, R. R. H., Pedersen, P. L., Souza, E. B. D., & Snyder, S. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36131-8 · Cited by 696
Progesterone synthesis and myelin formation by Schwann cells
Koenig, H. L., Schumacher, M., Ferzaz, B., Thi, A. N. D., Ressouches, A., Guennoun, R., Jung-Testas, I., Robel, P., Akwa, Y., & Baulieu, E.-E. (1995) · Science · doi:10.1126/science.7770777 · Cited by 480
Self-citationSchoemaker, H., Claustre, Y., Fage, D., Rouquier, L., Chergui, K., Curet, O., Oblin, A., Gonon, F., Carter, C. J., Bénavidès, J., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36395-5 · Cited by 371
Self-citationCytokine modulation by glucocorticoids: mechanisms and actions in cellular studies.
Brattsand, R., & Linden, M. (1996) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1996.22164025.x · Cited by 361
Krueger, K. E., & Papadopoulos, V. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77217-7 · Cited by 345
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney.
Schoemaker, H., Boles, R. G., Horst, W. D., & Yamamura, H. I. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33552-4 · Cited by 294
Cited by
Sorted by citations
Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930
Self-citationTranslocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers
Chauveau, F., Boutin, H., Camp, N. V., Dollé, F., & Tavitian, B. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0908-9 · Cited by 419
The facial nerve axotomy model
Moran, L. B., & Graeber, M. B. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.11.004 · Cited by 310
Bordet, T., Buisson, B., Michaud, M., Drouot, C., Galéa, P., Delaage, P., Akentieva, N., Evers, A. S., Covey, D. F., Ostuni, M. A., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123000 · Cited by 267
Self-citationVeenman, L., Papadopoulos, V., & Gavish, M. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781368710 · Cited by 249
Progesterone: Therapeutic opportunities for neuroprotection and myelin repair
Schumacher, M., Guennoun, R., Stein, D. G., & Nicola, A. F. D. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.001 · Cited by 247
Self-citationNeuroactive steroids: State of the art and new perspectives
Melcangi, R. C., García‐Segura, L. M., & Mensah‐Nyagan, A. G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7403-5 · Cited by 249
Veenman, L., & Gavish, M. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.007 · Cited by 192
Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma
Papadopoulos, V., & Lecanu, L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.016 · Cited by 178
Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169
Schumacher, M., Guennoun, R., Ghoumari, A. M., Massaad, C., Robert, F., El‐Etr, M., Akwa, Y., Rajkowski, K. M., & Baulieu, É.-É. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0050 · Cited by 170
Self-citationA TSPO ligand is protective in a mouse model of multiple sclerosis
Daugherty, D. J., Selvaraj, V., Chechneva, O. V., Liu, X., Pleasure, D., & Deng, W. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202124 · Cited by 158
Etifoxine improves peripheral nerve regeneration and functional recovery
Girard, C., Liu, S., Cadepond, F., Adams, D., Lacroix, C., Verleye, M., Gillardin, J., Baulieu, É.-É., Schumacher, M., & Schweizer-Groyer, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811201106 · Cited by 152
Self-citationZhang, M., Kida, T., Noguchi, J., Furutsuka, K., Maeda, J., Suhara, T., & Suzuki, K. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(03)00016-7 · Cited by 144
Chen, M., Baidoo, K. E., Verina, T., & Guilarte, T. R. (2004) · Brain · doi:10.1093/brain/awh161 · Cited by 140
Kita, A., Kohayakawa, H., Kinoshita, T., Ochi, Y., Nakamichi, K., Kurumiya, S., Furukawa, K., & Oka, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705681 · Cited by 124
Liere, P., Pianos, A., Eychenne, B., Cambourg, A., Liu, S., Griffiths, W., Schumacher, M., Sjövall, J., & Baulieu, E.-E. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400244-jlr200 · Cited by 118
Self-citationThe Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design
Scarf, A. M., Ittner, L. M., & Kassiou, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8011678 · Cited by 98
Veiga, S., Azcoitia, I., & Garcia-Segura, L. M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20430 · Cited by 101
Neuroactive steroids and peripheral neuropathy
Roglio, I., Giatti, S., Pesaresi, M., Bianchi, R., Cavaletti, G., Lauria, G., García‐Segura, L. M., & Melcangi, R. C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.010 · Cited by 92
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
Froestl, W., Muhs, A., & Pfeifer, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121186 · Cited by 94
Giatti, S., Pesaresi, M., Cavaletti, G., Bianchi, R., Carozzi, V., Lombardi, R., Maschi, O., Lauria, G., García‐Segura, L. M., Caruso, D., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.005 · Cited by 89
Augmented expression of TSPO after intracerebral hemorrhage: a role in inflammation?
Bonsack, F., Alleyne, C. H., & Sukumari‐Ramesh, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0619-2 · Cited by 98
Pozzo, E. D., Tremolanti, C., Costa, B., Giacomelli, C., Milenkovic, V. M., Bader, S. M., Wetzel, C. H., Rupprecht, R., Taliani, S., Settimo, F. D., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184467 · Cited by 89
Leducq, N., Bono, F., Sulpice, T., Vin, V., Janiak, P., Fur, G. L., O'Connor, S., & Herbert, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052068 · Cited by 86
Steroidogenic acute regulatory protein in the brain
Lavaque, E., Sierra, A., Azcoitia, I., & Garcia-Segura, L. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.060 · Cited by 81
Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa
Girard, C., Liu, S., Adams, D., Lacroix, C., Sinéus, M., Boucher, C., Papadopoulos, V., Rupprecht, R., Schumacher, M., & Groyer, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02215.x · Cited by 75
Self-citationOxidative Imbalance and Anxiety Disorders
Krolow, R., Arcego, D. M., Noschang, C. G., Weis, S. N., & Dalmaz, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223530 · Cited by 76
Chen, M., & Guilarte, T. R. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj172 · Cited by 70
TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy
Costa, B., Pozzo, E. D., Giacomelli, C., Barresi, E., Taliani, S., Settimo, F. D., & Martini, C. (2016) · Scientific Reports · doi:10.1038/srep18164 · Cited by 73
Immunohistochemical Assessment of the Peripheral Benzodiazepine Receptor in Human Tissues
Bribes, E., Carrière, D., Goubet, C., Galiègue, S., Casellas, P., & Joêlle, S.-L. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540405200103 · Cited by 65
Chauveau, F., Boutin, H., Camp, N. V., Thominiaux, C., Hantraye, P., Rivron, L., Marguet, F., Castel, M., Rooney, T., Bénavidès, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1628-5 · Cited by 61
Self-citationTSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis
Lejri, I., Grimm, A., Hallé, F., Abarghaz, M., Klein, C., Maître, M., Schmitt, M., Bourguignon, J., Mensah‐Nyagan, A. G., Bihel, F. J. ‐., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190127 · Cited by 68
An update on pharmacological approaches to neurodegenerative diseases
Scatena, R., Martorana, G. E., Bottoni, P., Botta, G., Pastore, P., & Giardina, B. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.1.59 · Cited by 62
Chen, C., Kuo, J., Wong, A., & Micevych, P. E. (2014) · Endocrinology · doi:10.1210/en.2013-1844 · Cited by 57
Karchewski, L. A., Bloechlinger, S., & Woolf, C. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03530.x · Cited by 56
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
Nothdurfter, C., Baghai, T. C., Schüle, C., & Rupprecht, R. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0352-5 · Cited by 60
Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role
Giatti, S., Diviccaro, S., Serafini, M. M., Caruso, D., García‐Segura, L. M., Viviani, B., & Melcangi, R. C. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100804 · Cited by 60
An update into the medicinal chemistry of translocator protein (TSPO) ligands
Barresi, E., Robello, M., Costa, B., Pozzo, E. D., Baglini, E., Salerno, S., Settimo, F. D., Martini, C., & Taliani, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112924 · Cited by 59
Role of Neuroactive Steroids in the Peripheral Nervous System
Melcangi, R. C., Giatti, S., Pesaresi, M., Calabrese, D., Mitro, N., Caruso, D., & García‐Segura, L. M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00104 · Cited by 51
Neuroactive steroids and the peripheral nervous system: An update
Giatti, S., Romano, S., Pesaresi, M., Cermenati, G., Mitro, N., Caruso, D., Tetel, M. J., García‐Segura, L. M., & Melcangi, R. C. (2015) · Steroids · doi:10.1016/j.steroids.2015.03.014 · Cited by 50
O'Brien, E. S., Gauthier, D., Riban, V., & Verleye, M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0687-3 · Cited by 58
Li, J., Wang, J., & Zeng, Y.-M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.027 · Cited by 47
On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis
Papadopoulos, V. (2013) · Endocrinology · doi:10.1210/en.2013-2033 · Cited by 49
Induced expressions of Rab24 GTPase and LC3 in nerve-injured motor neurons
Egami, Y., Kiryu‐Seo, S., Yoshimori, T., & Kiyama, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.171 · Cited by 45
Kim, T., & Pae, A. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1230606 · Cited by 47
Jarahi, M., Sheibani, V., Safakhah, H. A., Torkmandi, H., & Rashidy‐Pour, A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.043 · Cited by 43
Role of the peripheral benzodiazepine receptor in sensory neuron regeneration
Mills, C. D., Bitler, J. L., & Woolf, C. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.010 · Cited by 42
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection
Pozzo, E. D., Giacomelli, C., Barresi, E., Costa, B., Taliani, S., Settimo, F. D., & Martini, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150028 · Cited by 41
Leonelli, E., Yagüe, J. G., Ballabio, M., Azcoitia, Í., Magnaghi, V., Schumacher, M., García‐Segura, L. M., & Melcangi, R. C. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.06.001 · Cited by 41
Self-citationCurrent status and future perspectives: TSPO in steroid neuroendocrinology
Selvaraj, V., & Tu, L. N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0241 · Cited by 41
Ahmed, H. H., Elmegeed, G. A., El-Sayed, E.-S. M., Abdelhalim, M. M., Shousha, W. G., & Shafic, R. W. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.09.017 · Cited by 39
TSPO Radioligands for Neuroinflammation: An Overview
Salerno, S., Viviano, M., Baglini, E., Poggetti, V., Giorgini, D., Castagnoli, J., Barresi, E., Castellano, S., Settimo, F. D., & Taliani, S. (2024) · Molecules · doi:10.3390/molecules29174212 · Cited by 41
Binding characteristics of SSR180575, a potent and selective peripheral benzodiazepine ligand
Vin, V., Leducq, N., Bono, F., & Herbert, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.079 · Cited by 36
Ro5‐4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats
Mills, C., Makwana, M., Wallace, A., Benn, S., Schmidt, H., Tegeder, I., Costigan, M., Brown, R. H., Raivich, G., & Woolf, C. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06065.x · Cited by 35
Viviano, M., Barresi, E., Siméon, F. G., Costa, B., Taliani, S., Settimo, F. D., Pike, V. W., & Castellano, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220329204054 · Cited by 35
Therapeutic approaches to peripheral neuropathy based on neuroactive steroids
Melcangi, R. C., & García‐Segura, L. M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.8.1121 · Cited by 32
Molecular Imaging of the Translocator Protein (TSPO) in a Pre-Clinical Model of Breast Cancer
Wyatt, S. K., Manning, H. C., Bai, M., Bailey, S. N., Gallant, P., Ma, G., McIntosh, L. M., & Bornhop, D. J. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0270-8 · Cited by 31
Development of new indole-derived neuroprotective agents
Mohareb, R. M., Ahmed, H. H., Elmegeed, G. A., Abdelhalim, M. M., & Shafic, R. W. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.031 · Cited by 31
Luu, T. G., & Kim, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112545 · Cited by 32
Translocator protein in the rise and fall of central nervous system neurons
Cheung, G., Lin, Y. C., & Papadopoulos, V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1210205 · Cited by 33
Etifoxine provides benefits in nerve repair with acellular nerve grafts
Zhou, X., He, B., Zhu, Z., He, X., Zheng, C., Xu, J., Jiang, L., Gu, L., Zhu, J., Zhu, Q., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.24131 · Cited by 29
The translocator protein (18 kDa) and its role in neuropsychiatric disorders
Barichello, T., Simões, L. R., Collodel, A., Giridharan, V. V., Dal‐Pizzol, F., Macêdo, D. S., & Quevedo, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.010 · Cited by 30
Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System
Schumacher, M., Zhu, X., & Guennoun, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00054-7 · Cited by 30
Self-citationAntioxidant Activity and Neuroprotective Effects of Zolpidem and Several Synthesis Intermediates
García‐Santos, G., Herrera, F., Martı́n, V., Rodríguez‐Blanco, J., Antolı́n, I., Fernández-Marı́, F., & Rodrı́guez, C. (2004) · Free Radical Research · doi:10.1080/10715760400017343 · Cited by 28
Evaluating the Phase II drugs currently under investigation for diabetic neuropathy
Adeghate, E. A., Fehér, E., & Kalász, H. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.954033 · Cited by 28
Cappelli, A., Bini, G., Valenti, S., Giuliani, G., Paolino, M., Anzini, M., Vomero, S., Giorgi, G., Giordani, A., Stasi, L. P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200770f · Cited by 27
Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo
Bribes, E., Bourrié, B., & Casellas, P. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00083-x · Cited by 27
Cheung, Y., Nickels, M. L., Tang, D., Buck, J. R., & Manning, H. C. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.091 · Cited by 26
Leonelli, E., Ballabio, M., Consoli, A., Roglio, I., Magnaghi, V., & Melcangi, R. C. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:1:65 · Cited by 26
Roles of Mitochondrial Benzodiazepine Receptor in the Heart
Surinkaew, S., Chattipakorn, S. C., & Chattipakorn, N. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.023 · Cited by 27
Mechanisms of Repair after Traumatic Injury
HALL, S. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50061-2 · Cited by 25
An efficient synthesis of novel 1,3-oxazolo[4,5- d ]pyridazinones
Frolov, E. B., Lakner, F. J., Khvat, A. V., & Ivachtchenko, A. V. (2004) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.04.093 · Cited by 25
Metal complexes targeting the Translocator Protein 18 kDa (TSPO)
Denora, N., Iacobazzi, R. M., Natile, G., & Margiotta, N. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.03.023 · Cited by 24
Bribes, E., Bourrié, B., Esclangon, M., Galiègue, S., Vidal, H., & Casellas, P. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02231-8 · Cited by 24
The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system
Chemali, L. E., Akwa, Y., & Massaad-Massade, L. (2022) · Biochemical Journal · doi:10.1042/bcj20220050 · Cited by 30
Zwergal, A., Gunther, L. M., Brendel, M., Beck, R., Lindner, S., Xiong, G., Eilles, E., Unterrainer, M., Albert, N. L., Becker‐Bense, S., et al. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00665 · Cited by 22
Targeting Neuroprotection as an Alternative Approach to Preventing and Treating Neuropathic Pain
Bordet, T., & Pruss, R. M. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.07.001 · Cited by 24
Yanamoto, K., Kumata, K., Fujinaga, M., Nengaki, N., Takei, M., Wakizaka, H., Hosoi, R., Momosaki, S., Yamasaki, T., Yui, J., et al. (2010) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.04.183 · Cited by 22
Yu, W., Wang, E., Voll, R. J., Miller, A. H., & Goodman, M. M. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.046 · Cited by 21
Agnosic vision is like peripheral vision, which is limited by crowding
Strappini, F., Pelli, D. G., Pace, E. D., & Martelli, M. (2017) · Cortex · doi:10.1016/j.cortex.2017.01.012 · Cited by 22
Etifoxine promotes glial-derived neurotrophic factor-induced neurite outgrowth in PC12 cells
Zhou, X., HE, X., He, B., Zhu, Z., Zheng, C., Xu, J., Jiang, L., Gu, L., Zhu, J., Zhu, Q., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1474 · Cited by 20
Thominiaux, C., Damont, A., Kühnast, B., Demphel, S., Helleix, S. L., Boisnard, S., Rivron, L., Chauveau, F., Boutin, H., Camp, N. V., et al. (2010) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1794 · Cited by 20
Ma, B., Liu, X., Huang, X., Ji, Y. S., Jin, T., & Ma, K. (2017) · Molecular Pain · doi:10.1177/1744806917748019 · Cited by 19
Cappelli, A., Giuliani, G., Valenti, S., Anzini, M., Vomero, S., Giorgi, G., Sogliano, C., Maciocco, E., Biggio, G., & Concas, A. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.06.044 · Cited by 18
Expression of the Peripheral Benzodiazepine Receptor Triggers Thymocyte Differentiation
Rochard, P., Galiègue, S., Tinel, N., Péleraux, A., Bord, A., Jbilo, O., & Casellas, P. (2004) · Gene Expression · doi:10.3727/000000004783992170 · Cited by 18
Rahman, O., & Långström, B. (2007) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1437 · Cited by 18
Vicente-Rodríguez, M., Mancuso, R., Peris-Yague, A., Simmons, C., NIMA Consortium, Wlazly, D., Dickinson, A., Foster, A., Knight, C., Leckey, C., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02769-y · Cited by 17
The Ligands of Translocator Protein: Design and Biological Properties
Мокров, Г. В., Деева, О. А., & Гудашева, Т. А. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200903122025 · Cited by 18
Brain steroidogenesis: emerging therapeutic strategies to prevent neurodegeneration
Azcoitia, Í., Sierra, A., Veiga, S. J., & García‐Segura, L. M. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0179-y · Cited by 17
Peripheral benzodiazepine receptors on platelets of fibromyalgic patients
Bazzichi, L., Giannaccini, G., Betti, L., Italiani, P., Fabbrini, L., DeFeo, F. G., Giacomelli, C., Giuliano, T., Rossi, A., Uccelli, A., et al. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.06.002 · Cited by 16
Investigation Into the Role of ERK in Tyrosine Kinase Inhibitor-Induced Neuropathy
Belair, D. G., Sudak, K., Connelly, K., Collins, N. D., Kopytek, S., & Kolaja, K. L. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab033 · Cited by 14
A Protective Role of Translocator Protein in Alzheimer’s Disease Brain
Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 17
Hallé, F., Lejri, I., Abarghaz, M., Grimm, A., Klein, C., Maître, M., Schmitt, M., Bourguignon, J., Mensah‐Nyagan, A. G., Eckert, A., et al. (2017) · ChemistrySelect · doi:10.1002/slct.201701565 · Cited by 17
Fukaya, T., Kodo, T., Ishiyama, T., Nishikawa, H., Baba, S., & Masumoto, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.12.024 · Cited by 13
Leducq, N., Vin, V., Savi, P., & Bono, F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.011 · Cited by 13
Bribes, E., Galiègue, S., Bourrié, B., & Casellas, P. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00177-3 · Cited by 13
Fairley, L. H., Lai, K. O., Grimm, A., Eckert, A., & Barron, A. M. (2024) · Biochimie · doi:10.1016/j.biochi.2024.07.003 · Cited by 14
Bloms‐Funke, P., Schumacher, M., Liu, S., Su, D., Li, J., Lière, P., Rupprecht, R., Nothdurfter, C., Bahrenberg, G., Christoph, T., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174935 · Cited by 14
Self-citation
Metadata
- Authors
- Ferzaz, B., Brault, E., Bourliaud, G., Robert, J.-P., Poughon, G., Claustre, Y., Marguet, F., Liere, P., Schumacher, M., Nowicki, J.-P., Fournier, J., Marabout, B., Sevrin, M., George, P., Soubrie, P., Benavides, J., & Scatton, B.
- Affiliations
- Sanofi (France) (FR)
- ORCID
- Scatton, Bernard
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 301
- Issue
- 3
- Pages
- 1067-1078
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2155301275
- Cited by
- 126
- References
- 41
- Citations by year
- 2024: 5 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 4 · 2017: 7 · 2016: 11 · 2015: 3 · 2014: 4 · 2013: 6 · 2012: 3
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- translocator protein (TSPO), neuroprotection, motor neuron degeneration, facial nerve axotomy, pregnenolone, peripherin, nerve regeneration, functional recovery, blink reflex
- MeSH terms
- Acetamides, Aging, Animals, Binding, Competitive, Cell Survival, Facial Nerve, Humans, Imidazoles, Indoles, Ligands, Male, Motor Neurons, Pyridazines, Pyridines, Receptors, GABA-A, Anti-Anxiety Agents, Rats, Sprague-Dawley, Neuroprotective Agents, Axotomy, Rats, GABA-A Receptor Agonists, GABA-A Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review